The markets extended its gains during the midday with the Dow soaring 114 points to 14,774 as consumer confidence jumped in June. Nasdaq gained 24 points to 3345.
On the upside
J. P. Morgan initiated coverage of First Solar (Nasdaq: FSLR) yesterday with an Overweight rating and set a price target of $64.
Peregrine Pharmaceuticals (Nasdaq: PPHM) will be added to the Russell 3000 and Russell Global Indexes on June 28, 2013.
Bargain hunters snapped up shares of e-Commerce China Dangdang (NYSE: DANG).
On the downside
Demand Media (NYSE: DMD) lowered its revenue guidance for the second quarter and withdrew its full year outlook prompting downgrades.
Investors locked in profits on Isis Pharmaceuticals (Nasdaq: ISIS).
Seattle Genetics (NYSE: SGEN) temporarily stopped a clinical study treating Hodgkin lymphoma patients with Adcetris and chemotherapy due to safety concerns.
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE by nearly 7 to 3 on Nasdaq. The broader S&P 500 index climbed 14 points to 1587.
